Hepatic haemangioendothelioma in adults: excellent outcome following liver transplantation

被引:40
作者
Lerut, JP
Orlando, G
Sempoux, C
Ciccarelli, O
Van Beers, BE
Danse, E
Horsmans, Y
Rahier, J
Roggen, F
机构
[1] Catholic Univ Louvain, Liver Transplant Program, Dept Digest Surg, Clin Univ St Luc 1400, B-1200 Brussels, Belgium
[2] Catholic Univ Louvain, Liver Transplant Program, Dept Pathol, Clin Univ St Luc, B-1200 Brussels, Belgium
[3] Catholic Univ Louvain, Liver Transplant Program, Dept Radiol, Clin Univ St Luc, B-1200 Brussels, Belgium
[4] Catholic Univ Louvain, Liver Transplant Program, Dept Gastroenterol, Clin Univ St Luc, B-1200 Brussels, Belgium
关键词
liver vascular tumour; haemangioendothelioma; liver transplantation;
D O I
10.1111/j.1432-2277.2004.tb00429.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hepatic epithelioid haemangioendotheliomas (HEHEs) are rare, low-grade vascular tumours. Five adults with HEHEs and one adult with a vascular tumour showing combined features of haemangioma and haemangioendothelioma underwent liver transplantation. Two HEHE patients had extrahepatic metastases at the time of transplantation. Median survival time following diagnosis was 10.7 years (range 40 months to 195 months). One patient needed resection of a HEHE in the breast 13 years post-transplantation. All six patients are surviving free from disease 22 to 166 months after transplantation (median 77 months). One HEHE-patient who had been treated for 8 years for vertebral and cerebral localisations is free of disease without immunosuppression 56 months after transplantation. We can conclude that liver transplantation is a valuable treatment for hepatic haemangioendothelioma, even in cases of extrahepatic localisation of the disease.
引用
收藏
页码:202 / 207
页数:6
相关论文
共 31 条
  • [1] BANCEL B, 1993, ANN PATHOL, V13, P23
  • [2] Hepatic epithelioid hemangioendothelioma: Resection or transplantation, which and when?
    Ben-Haim, M
    Roayaie, S
    Ye, MQ
    Thung, SN
    Emre, S
    Fishbein, TA
    Sheiner, PM
    Miller, CM
    Schwartz, ME
    [J]. LIVER TRANSPLANTATION AND SURGERY, 1999, 5 (06): : 526 - 531
  • [3] DACHMAN AH, 1983, AM J ROENTGENOL, V140, P1091, DOI 10.2214/ajr.140.6.1091
  • [4] DAIL DH, 1983, CANCER, V51, P452, DOI 10.1002/1097-0142(19830201)51:3<452::AID-CNCR2820510317>3.0.CO
  • [5] 2-M
  • [6] Hepatic hemangioendothelioma: Clinical experience and management strategy
    Daller, JA
    Bueno, J
    Gutierrez, J
    Dvorchik, I
    Towbin, RB
    Dickman, PS
    Mazariegos, G
    Reyes, J
    [J]. JOURNAL OF PEDIATRIC SURGERY, 1999, 34 (01) : 98 - 105
  • [7] MALIGNANT EPITHELIOID HEMANGIOENDOTHELIOMA OF THE LIVER IN YOUNG-WOMEN - RELATIONSHIP TO ORAL-CONTRACEPTIVE USE
    DEAN, PJ
    HAGGITT, RC
    OHARA, CJ
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1985, 9 (10) : 695 - 704
  • [8] DEHNER LP, 1971, ARCH PATHOL, V92, P101
  • [9] Hepatic epithelioid hemangioendothelioma - Biological questions based on pattern of recurrence in an allograft and tumor immunophenotype
    Demetris, AJ
    Minervini, M
    Raikow, RB
    Lee, RG
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (03) : 263 - 270
  • [10] MALIGNANT EPITHELIOID HEMANGIOENDOTHELIOMA OF THE LIVER - A CLINICOPATHOLOGICAL AND HISTOCHEMICAL-STUDY OF 12 CASES
    DIETZE, O
    DAVIES, SE
    WILLIAMS, R
    PORTMANN, B
    [J]. HISTOPATHOLOGY, 1989, 15 (03) : 225 - 237